Join to View Full Profile
Amgen - One Amgen Center DriveMail Stop 38-3-BThousand Oaks, CA 91320
Phone+1 805-490-0300
Are you Dr. Davar?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Gudarz Davar, MD is a board certified neurologist in Thousand Oaks, California. He is currently licensed to practice medicine in Massachusetts. He is a Section Head at Allergan.
Education & Training
Mass General Brigham/Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1988 - 1989- Mass General Brigham/Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1986 - 1988
University of MichiganResidency, Neurology, 1983 - 1986
Dalhousie University Faculty of MedicineClass of 1982
Certifications & Licensure
MA State Medical License 1986 - 2025
American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 32 citationsUtilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine from an observational study in EuropeManjit Matharu, Julio Pascual, Ingela Nilsson Remahl, Andreas Straube, Arlene Lum
Cephalalgia. 2017-07-31 - 91 citationsA Novel PEGylated Interferon Beta‐1a for Multiple Sclerosis: Safety, Pharmacology, and BiologyXiao Hu, Larisa Miller, Sandra Richman, Stacy Hitchman, Gabrielle Glick
Journal of Clinical Pharmacology. 2012-06-01 - 29 citationsPEGylated interferon beta-1a: meeting an unmet medical need in the treatment of relapsing multiple sclerosis.Darren P. Baker, R. B. Pepinsky, Margot Brickelmaier, Robert S. Gronke, Xiao Hu
Journal of Interferon & Cytokine Research. 2010-09-27
Press Mentions
Chutes & Ladders—AltruBio Snags New CMO with Resume at Sublimity, Ardea, Amgen and AbbottSeptember 17th, 2021- A Pfizer Partner Welcomes Ex-ADC Therapeutics CMO Jay Feingold to the Team; Amid Tough Sledding, Immunovant Chooses Eli Lilly Alum as CFOSeptember 17th, 2021
- Autobahn Therapeutics Strengthens Management Team to Support Advancement of Novel Therapies for CNS DisordersSeptember 14th, 2021
- Join now to see all
